Your Dividend Fortress: 2 Pharma Stocks Among 5 “Never-Sell” Picks Sep 28, 2025 Consumer Goods, Financial Service, Life Science
Pfizer’s Multi-Billion Dollar Acquisition of Metsera: A Key Move to Reshape the Weight-Loss Drug Landscape Sep 26, 2025 Life Science
Opportunities from the Dip? Analyzing Novo Nordisk’s Three Fundamental Pillars Sep 25, 2025 Life Science
Splashing Out 5 Billion! Unveiling Lilly’s Next Growth Engine After the Weight-Loss Injection Sep 24, 2025 Life Science
Positive Results from Investigational Drug Trial, Atai Life Sciences Stock Soars Accordingly Sep 23, 2025 Life Science
Regulatory Tailwinds and Analyst Optimism: A Double Dose of Good News for BioNTech’s Stock Sep 23, 2025 Life Science
Steady Your Portfolio with These Two “Dividend Kings” Boasting Over 50 Years of Payout Growth Sep 21, 2025 Consumer Goods, Life Science
Highly Regarded by Multiple Institutions, CRISPR Therapeutics Leads Gene Editing Therapy with a Diverse Pipeline Sep 18, 2025 Life Science
Eli Lilly’s Strong Oral Weight-Loss Drug Data Solidifies Its Leading Position in the GLP-1 Market Sep 18, 2025 Life Science
